{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:13:11Z","timestamp":1790097191149,"version":"4.0.1"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.23677","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T11:46:28Z","timestamp":1604490388000},"page":"e2023677","source":"Crossref","is-referenced-by-count":48,"title":["Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US"],"prefix":"10.1001","volume":"3","author":[{"given":"Jeromie","family":"Ballreich","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Monument Analytics, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Mansour","sequence":"additional","affiliation":[{"name":"Monument Analytics, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Hu","sequence":"additional","affiliation":[{"name":"Monument Analytics, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Chingcuanco","sequence":"additional","affiliation":[{"name":"Monument Analytics, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Pollack","sequence":"additional","affiliation":[{"name":"Monument Analytics, Baltimore, Maryland"},{"name":"The University of Chicago School of Social Service Administration, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Monument Analytics, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Monument Analytics, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Medicine, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"issue":"5152","key":"zoi200785r1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013-2017.","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50-51","key":"zoi200785r3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi200785r4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose.","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"6408","key":"zoi200785r5","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.","volume":"361","author":"Jalal","year":"2018","journal-title":"Science"},{"issue":"5","key":"zoi200785r6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11916-018-0685-5","article-title":"America\u2019s opioid epidemic: a comprehensive review and look into the rising crisis.","volume":"22","author":"Ostling","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"zoi200785r7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","article-title":"Modeling health benefits and harms of public policy responses to the US opioid epidemic.","volume":"108","author":"Pitt","year":"2018","journal-title":"Am J Public Health"},{"issue":"6","key":"zoi200785r8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/00952990.2015.1043435","article-title":"Dynamic model of nonmedical opioid use trajectories and potential policy interventions.","volume":"41","author":"Wakeland","year":"2015","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"zoi200785r9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States.","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi200785r10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.v114.9","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"issue":"3","key":"zoi200785r12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCOUTCOMES.109.910711","article-title":"Future cardiovascular disease in china: Markov model and risk factor scenario projections from the coronary heart disease policy model-china.","volume":"3","author":"Moran","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"zoi200785r13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.18001\/TRS.1.2.3","article-title":"Markov modeling to estimate the population impact of emerging tobacco products: a proof-of-concept study.","volume":"1","author":"Cobb","year":"2015","journal-title":"Tob Regul Sci"},{"key":"zoi200785r18","doi-asserted-by":"publisher","first-page":"k791","DOI":"10.1136\/bmj.k791","article-title":"OxyContin maker stops marketing opioids, as report details payments to advocacy groups.","volume":"360","author":"Dyer","year":"2018","journal-title":"BMJ"},{"issue":"15","key":"zoi200785r20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"13","key":"zoi200785r24","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"zoi200785r26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1300\/J465v27n03_07","article-title":"Duration of nonmethadone outpatient treatment: results from a national survey.","volume":"27","author":"Friedmann","year":"2006","journal-title":"Subst Abus"},{"issue":"3","key":"zoi200785r27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2105\/AJPH.2018.304856","article-title":"Impact of Medicaid restrictions on availability of buprenorphine in addiction treatment programs.","volume":"109","author":"Andrews","year":"2019","journal-title":"Am J Public Health"},{"issue":"11","key":"zoi200785r28","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jamainternmed.2016.5381","article-title":"2016 Update on medical overuse: a systematic review.","volume":"176","author":"Morgan","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"5","key":"zoi200785r29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11606-016-3587-4","article-title":"Capsule Commentary on Calcaterra et al., Opioid prescribing at hospital discharge contributes to chronic opioid use.","volume":"31","author":"Subramani","year":"2016","journal-title":"J Gen Intern Med"},{"key":"zoi200785r30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"zoi200785r31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use.","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"zoi200785r32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0731-2199(05)16019-1","article-title":"Models pertaining to how drug policy should vary over the course of a drug epidemic.","volume":"16","author":"Caulkins","year":"2005","journal-title":"Adv Health Econ Health Serv Res"},{"key":"zoi200785r33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1257\/pol.20170082","article-title":"Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids.","volume":"10","author":"Alpert","year":"2018","journal-title":"Am Econ J Econ Policy."},{"key":"zoi200785r36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.033","article-title":"Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis.","volume":"165","author":"Chang","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"zoi200785r2","first-page":"272","author":"Phillips","year":"2017"},{"key":"zoi200785r17","volume-title":"Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III).","author":"Grant","year":"2014"},{"key":"zoi200785r22","volume-title":"The Opioid Epidemic: From Evidence to Impact.","author":"Alexander","year":"2017"},{"key":"zoi200785r25","author":"Mackey","year":"2019"},{"key":"zoi200785r34","doi-asserted-by":"crossref","DOI":"10.7249\/RR534","volume-title":"What America\u2019s Users Spend on Illegal Drugs: 2000-2010","author":"Kilmer","year":"2014"},{"key":"zoi200785r11","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Rates of nonmedical prescription opioid use and opioid use disorder double in 10 years. Published June 22, 2016. Accessed December 10, 2018. https:\/\/www.niaaa.nih.gov\/news-events\/news-releases\/rates-nonmedical-prescription-opioid-use-and-opioid-use-disorder-double-10"},{"key":"zoi200785r14","unstructured":"Census? US. Accessed January 23, 2020. https:\/\/www.census.gov"},{"key":"zoi200785r15","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. CDC WONDER. About multiple cause of death, 1999-2017. Accessed January 23, 2020. https:\/\/wonder.cdc.gov\/mcd-icd10.html"},{"key":"zoi200785r16","unstructured":"US Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Results from the 2017 National Survey on Drug Use and Health: detailed tables. Accessed January 23, 2020. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHDetailedTabs2017\/NSDUHDetailedTabs2017.pdf"},{"key":"zoi200785r19","unstructured":"Drug Enforcement Agency, Diversion Control Division. FR Doc No: 2018-15141. Accessed January 23, 2020. https:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2018\/fr0716_3.htm"},{"key":"zoi200785r21","doi-asserted-by":"crossref","unstructured":"Midgette G, Davenport S, Caulkins JP, Kilmer B. What America\u2019s users spend on illegal drugs, 2006-2016. RAND. Published 2019. Accessed August 17, 2020. https:\/\/www.rand.org\/content\/dam\/rand\/pubs\/research_reports\/RR3100\/RR3140\/RAND_RR3140.pdf","DOI":"10.7249\/RR3140"},{"key":"zoi200785r23","unstructured":"Gramlich? J. What the data says about gun deaths in the US. Pew Research Center. Published August 16, 2019. Accessed January 23, 2020. https:\/\/www.pewresearch.org\/fact-tank\/2019\/08\/16\/what-the-data-says-about-gun-deaths-in-the-u-s\/"},{"key":"zoi200785r35","doi-asserted-by":"crossref","unstructured":"Pardo? B, Taylor J,? Caulkins JP, et al. The Future of Fentanyl and Other Synthetic Opioids. RAND Corporation. Published 2019. Accessed January 23, 2020. https:\/\/www.rand.org\/pubs\/research_reports\/RR3117.html","DOI":"10.7249\/RR3117"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2772525\/ballreich_2020_oi_200785_1603750381.4183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T11:46:48Z","timestamp":1604490408000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2772525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.23677","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}